Diagnostics

Use of AD blood-based biomarkers for trial enrolment

Expanding research into biomarkers for RPD differentiation

How feasible is an Alzheimer’s disease blood test in the UK?

Streamlining dementia diagnosis with digital biomarkers

Digital markers detect changes in neurocognitive performance in those with vs without hearing loss

The reality of implementing an Alzheimer’s disease ‘blood test’ in clinical practice

Research needs: determining reliability and robustness of plasma markers in Alzheimer’s disease

Facilitation of dementia diagnosis across the world

Blood biomarkers for the differential diagnosis of Alzheimer’s disease in clinical practice

Decreased kidney function associated with increased plasma p-tau levels

Validating blood-based biomarker assays for use in Alzheimer’s disease clinical care

Assessing depressive symptoms in dementia screening

Why does tau-PET not detect the earliest stages of Alzheimer’s disease?

Alzheimer’s disease subtypes identified based on blood proteomics

Depressive symptom assessment can accurately detect cognitive decline

Access to Alzheimer’s disease diagnostic biomarkers in clinical routine